Literature DB >> 17218800

Lithium's effect in forced-swim test is blood level dependent but not dependent on weight loss.

Yuly Bersudsky1, Alona Shaldubina, R H Belmaker.   

Abstract

The effects of lithium in models of depression are often inconsistent. We aimed to replicate a regimen that induces robust antidepressant effects in the forced-swim test. Mice were treated with three different doses of lithium chloride (LiCl) 0.25, 0.4 or 0.5% in food and the forced-swim test or open field test was performed on day 15. We yoked control mice to food deprivation to test whether lithium-induced food deprivation could cause the lithium effects in the forced-swim test. Treatment with LiCl doses leading to blood levels of 1.3 and 1.4 mmol/l led to highly significant reduction in immobility time in the forced-swim test, but the dose leading to a blood level of 0.8 mmol/l was not different from controls in immobility time. Mice yoked to lithium-induced food deprivation showed no difference in the forced-swim test compared with controls. In conclusion these results suggest that lithium effects in mice in the forced-swim test are dose dependent but not owing to lithium-induced weight loss.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17218800     DOI: 10.1097/FBP.0b013e32801416ed

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  21 in total

1.  NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy.

Authors:  Raquel Gómez-Sintes; José J Lucas
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

Review 2.  Strategies for Treatment-Resistant Depression: Lessons Learned from Animal Models.

Authors:  Gislaine Zilli Réus; Airam Barbosa de Moura; Laura Araújo Borba; Helena Mendes Abelaira; João Quevedo
Journal:  Mol Neuropsychiatry       Date:  2019-05-21

3.  Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential.

Authors:  Wenzhong William Min; Christopher J Yuskaitis; Qijiang Yan; Christopher Sikorski; Shengqiang Chen; Richard S Jope; Robert P Bauchwitz
Journal:  Neuropharmacology       Date:  2008-10-14       Impact factor: 5.250

4.  Inositol-related gene knockouts mimic lithium's effect on mitochondrial function.

Authors:  Lilach Toker; Yuly Bersudsky; Inbar Plaschkes; Vered Chalifa-Caspi; Gerard T Berry; Roberto Buccafusca; Dieder Moechars; R H Belmaker; Galila Agam
Journal:  Neuropsychopharmacology       Date:  2013-08-08       Impact factor: 7.853

5.  Adult hippocampal neurogenesis is not necessary for the response to lithium in the forced swim test.

Authors:  Melinda E Snitow; Giulia Zanni; Brianna Ciesielski; Pamela Burgess-Jones; Amelia J Eisch; W Timothy O'Brien; Peter S Klein
Journal:  Neurosci Lett       Date:  2019-03-30       Impact factor: 3.046

6.  Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features.

Authors:  Jordy van Enkhuizen; Morgane Milienne-Petiot; Mark A Geyer; Jared W Young
Journal:  Psychopharmacology (Berl)       Date:  2015-07-05       Impact factor: 4.530

Review 7.  Lithium: a promising treatment for fragile X syndrome.

Authors:  Zhonghua Liu; Carolyn Beebe Smith
Journal:  ACS Chem Neurosci       Date:  2014-05-15       Impact factor: 4.418

Review 8.  Lithium and cognitive enhancement: leave it or take it?

Authors:  Eleftheria Tsaltas; Dimitris Kontis; Vasileios Boulougouris; George N Papadimitriou
Journal:  Psychopharmacology (Berl)       Date:  2008-09-10       Impact factor: 4.530

9.  The inositol monophosphatase inhibitor L-690,330 affects pilocarpine-behavior and the forced swim test.

Authors:  Liza Shtein; Lilach Toker; Yuly Bersudsky; R H Belmaker; Galila Agam
Journal:  Psychopharmacology (Berl)       Date:  2013-01-24       Impact factor: 4.530

10.  Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test.

Authors:  Todd D Gould; Kelley C O'Donnell; Eliot R Dow; Jing Du; Guang Chen; Husseini K Manji
Journal:  Neuropharmacology       Date:  2007-11-17       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.